Results 251 to 260 of about 1,052,864 (307)

Safety, efficacy, and distal nerve Schwann cell biodistribution in mice and NHPs to support translation of AAV9 RNAi therapy for CMT1A. [PDF]

Mol Ther Nucleic Acids
Stavrou M, Wallace LM, Thangaraj MP, Taylor NK, Kagiava A, Papacharalambous R, McAllister C, Zender G, Saad NY, Bayazit MB, Heslegrave A, Tryfonos C, Richter J, Zetterberg H, Price B, Salzman R, Kleopa KA, Harper SQ.   +17 more
europepmc   +1 more source

Oxaliplatin induced peripheral neuropathy and associated factors among colorectal cancer patients in Tanzania. [PDF]

BMC Cancer
Gonjobe MS, Dharsee N, Mduma E, Maunda KK.   +3 more
europepmc   +1 more source

Population Pharmacokinetic Modeling of Intravenous Topiramate in Patients with Epilepsy or Migraine. [PDF]

J Clin Pharmacol
Bamgboye AO, Coles LD, Suriyapakorn B, Mishra U, Kriel RL, Leppik IE, White JR, Cloyd JC.   +7 more
europepmc   +1 more source

Peripheral RIPK2 degradation improves neurological outcomes after experimental ischemic stroke. [PDF]

J Cereb Blood Flow Metab
Howell JA, Larochelle J, Strawser M, De La Vega Mulet S, Tishko R, Gunraj R, Liu L, Candelario-Jalil E.   +7 more
europepmc   +1 more source

Acute Retinal Necrosis in an Infant With Corneal and Macular Scarring. [PDF]

J Vitreoretin Dis
Zaidi Z, Hansen C, Dogan S, Wang AL.
europepmc   +1 more source

Possible preventive effect of surgical glove compression therapy on oxaliplatin-induced peripheral neuropathy: study protocol of a multicentre, phase II/III, randomised controlled trial-the Hiroshima Surgical Study Group of Clinical Oncology (HiSCO)-12 trial. [PDF]

BMJ Open
Shimomura M, Ishikawa S, Miguchi M, Shinozaki K, Ikeda S, Kobayashi H, Nakahara M, Sumitani D, Shimizu W, Kohyama M, Saito Y, Mukai S, Hirata Y, Kochi M, Shimizu Y, Takakura Y, Yoshimitsu M, Kodama S, Uegami S, Yano T, Okuda H, Ohdan H, Hiroshima Surgical study group of Clinical Oncology (HiSCO).   +22 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Peripheral doses in CyberKnife radiosurgery

Medical Physics, 2006
The purpose of this work is to measure the dose outside the treatment field for conformal CyberKnife treatments, to compare the results to those obtained for similar treatments delivered with gamma knife or intensity-modulated radiation therapy (IMRT), and to investigate the sources of peripheral dose in CyberKnife radiosurgery.
Paula L. Petti, Cynthia F. Chuang, Vernon Smith, David A. Larson   +3 more
openaire   +3 more sources

Peripheral doses from pediatric IMRT

Medical Physics, 2006
Peripheral dose (PD) data exist for conventional fields and intensity‐modulated radiotherapy (IMRT) delivery to standard adult‐sized phantoms. Pediatric peripheral dose reports are limited to conventional therapy and are model based. Our goal was to ascertain whether data acquired from full phantom studies and/or pediatric models, with IMRT treatment ...
Eric E, Klein, Beth, Maserang, Roy, Wood, David, Mansur   +3 more
openaire   +2 more sources

Peripheral Neuropathy and Low Dose Cisplatin

American Journal of Clinical Oncology, 1988
Five of 55 patients with metastatic carcinomas or unresectable primary carcinomas developed a peripheral neuropathy with "low dose" cisplatin therapy, consisting of 20 mg/m2 weekly. The neuropathy was primarily sensory, consisting of painful parasthesias and numbness in a "stocking glove" distribution.
A, Greenspan, J, Treat
openaire   +2 more sources